Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua R Steinerman

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Current Neurology and Neuroscience Reports|June 15, 2010
Minding the aging brain: technology-enabled cognitive training for healthy eldersJoshua R Steinerman
Current Neurology and Neuroscience Reports|September 4, 2007
Laboratory biomarkers in Alzheimer's diseaseJoshua R Steinerman, Lawrence S Honig
Frontiers in Aging Neuroscience|December 2, 2010
Training cognitive control in older adults with the space fortress game: the role of training instructions and basic motor abilityHelena M Blumen, Daniel Gopher, Joshua R Steinerman, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 18, 2017
Time course of glatiramer acetate efficacy in patients with RRMS in the GALA studyMat D Davis, Natalia Ashtamker, Joshua R Steinerman, et al.
Neurology|May 17, 2013
Nonmelanoma skin cancer is associated with reduced Alzheimer disease riskRobert S White, Richard B Lipton, Charles B Hall, et al.
Journal of the American Geriatrics Society|October 30, 2010
Modeling cognitive trajectories within longitudinal studies: a focus on older adultsJoshua R Steinerman, Charles B Hall, Martin J Sliwinski, et al.
Journal of Neurology|December 28, 2014
Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense "black holes": a post hoc magnetic resonance imaging analysisRobert Zivadinov, Michael Dwyer, Hadas Barkay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 21, 2017
Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMSFrancesca Bovis, Nicola De Stefano, Joshua R Steinerman, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|September 23, 2015
The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing-Remitting Multiple SclerosisRobert Zivadinov, Michael G Dwyer, Deepa P Ramasamy, et al.
Multiple Sclerosis and Related Disorders|May 20, 2023
Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trialsJacqueline Nicholas, Fred Lublin, Sylvia Klineova, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Neurology and Neuroscience Reports|June 15, 2010
Minding the aging brain: technology-enabled cognitive training for healthy eldersJoshua R Steinerman
Current Neurology and Neuroscience Reports|September 4, 2007
Laboratory biomarkers in Alzheimer's diseaseJoshua R Steinerman, Lawrence S Honig
Frontiers in Aging Neuroscience|December 2, 2010
Training cognitive control in older adults with the space fortress game: the role of training instructions and basic motor abilityHelena M Blumen, Daniel Gopher, Joshua R Steinerman, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 18, 2017
Time course of glatiramer acetate efficacy in patients with RRMS in the GALA studyMat D Davis, Natalia Ashtamker, Joshua R Steinerman, et al.
Neurology|May 17, 2013
Nonmelanoma skin cancer is associated with reduced Alzheimer disease riskRobert S White, Richard B Lipton, Charles B Hall, et al.
Journal of the American Geriatrics Society|October 30, 2010
Modeling cognitive trajectories within longitudinal studies: a focus on older adultsJoshua R Steinerman, Charles B Hall, Martin J Sliwinski, et al.
Journal of Neurology|December 28, 2014
Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense "black holes": a post hoc magnetic resonance imaging analysisRobert Zivadinov, Michael Dwyer, Hadas Barkay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 21, 2017
Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMSFrancesca Bovis, Nicola De Stefano, Joshua R Steinerman, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|September 23, 2015
The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing-Remitting Multiple SclerosisRobert Zivadinov, Michael G Dwyer, Deepa P Ramasamy, et al.
Multiple Sclerosis and Related Disorders|May 20, 2023
Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trialsJacqueline Nicholas, Fred Lublin, Sylvia Klineova, et al.
Pageof 3